Abstract

Preview
Over the past four months, COVID-19, the disease associated with the severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2), emerged in Wuhan and the Hubei province of China1 and spread worldwide, overwhelming healthcare systems and causing significant mortality. Among Western countries, Italy, and in particular the northern regions, were the first to have to face the COVID-19 epidemic emergency, at a time when knowledge about the disease was limited and little data about management and treatment were available in the literature. [ … ]

Downloads

Authors

Antonio Coppola - Regional Reference Center for Inherited Bleeding Disorders, University Hospital of Parma, Parma, Italy

Maria Lombardi - Internal Medicine, Angiology and Coagulation Unit, University Hospital of Parma, Parma, Italy

Maria I. Tassoni - Internal Medicine, Angiology and Coagulation Unit, University Hospital of Parma, Parma, Italy

Gaetano Carolla - Internal Medicine, Angiology and Coagulation Unit, University Hospital of Parma, Parma, Italy

Maurizio Tala - Haemostasis and Thrombosis Center, Cremona Hospital, Cremona, Italy

Rossella Morandini - Haemostasis and Thrombosis Center, Cremona Hospital, Cremona, Italy

Oriana Paoletti - Haemostasis and Thrombosis Center, Cremona Hospital, Cremona, Italy

Sophie Testa - Haemostasis and Thrombosis Center, Cremona Hospital, Cremona, Italy

  • Abstract viewed - 381 times
  • PDF downloaded - 26 times